DrReposER ID |
PDB |
Ligand |
Organism |
Macromolecule |
Pfam |
Res. |
Interface |
HETATM |
1C9H_A_RAPA108 |
1c9h |
RAP DB00877(Sirolimus) |
Homo sapiens |
FKBP12.6 |
PF00254(FKBP_C) |
13 |
TYR A 26ASP A 37PHE A 46GLN A 53GLU A 54VAL A 55ILE A 56PHE A 59TYR A 82HIS A 87VAL A 90ILE A 91PHE A 99 |
RAP A 108
|
1CQP_A_803A311 |
1cqp |
803 DB00227(Lovastatin) |
Homo sapiens |
ANTIGEN CD11A (P180) |
PF00092(VWA)no annotation |
10 |
LEU A 132VAL A 233ILE A 235TYR A 257LYS A 287LEU A 298GLU A 301LEU A 302LYS A 305VAL B 308 |
803 A 311
|
1CQP_B_803B311 |
1cqp |
803 DB00227(Lovastatin) |
Homo sapiens |
ANTIGEN CD11A (P180) |
PF00092(VWA)no annotation |
7 |
LEU B 132VAL B 233TYR B 257LYS B 287LEU B 298LEU B 302VAL A 308 |
803 B 311
|
2F16_2_BO221405 |
2f16 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME COMPONENTPRE3;PROTEASOME COMPONENTPUP1 |
PF00227(Proteasome)no annotation |
13 |
THR 2 1THR 2 20THR 2 21THR 2 22ALA 2 27LYS 2 33ARG 2 45SER 2 46GLY 2 47ALA 2 49HIS V 114SER V 118SER 2 168 |
BO2 21405
|
2F16_H_BO2H1400 |
2f16 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME COMPONENTPUP1;PROTEASOME COMPONENTPUP3 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
11 |
THR H 1SER H 20GLN H 22ALA H 27LYS H 33ALA H 46GLY H 47THR H 48ALA H 49ASP I 114CYS I 118 |
BO2 H1400
|
2F16_N_BO2N1404 |
2f16 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME COMPONENTPRE3;PROTEASOME COMPONENTPUP1 |
PF00227(Proteasome)PF12465(Pr_beta_C)no annotation |
13 |
THR N 1THR N 20THR N 21THR N 22ALA N 27LYS N 33ARG N 45SER N 46GLY N 47ALA N 49HIS H 114SER H 118SER N 168 |
BO2 N1404
|
2F16_V_BO2V1401 |
2f16 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME COMPONENTPUP1;PROTEASOME COMPONENTPUP3 |
no annotation |
11 |
THR V 1SER V 20GLN V 22ALA V 27LYS V 33ALA V 46GLY V 47THR V 48ALA V 49ASP W 114CYS W 118 |
BO2 V1401
|
2GSS_A_EAAA0 |
2gss |
EAA DB00903(Etacrynicacid) |
Homo sapiens |
GLUTATHIONES-TRANSFERASE P1-1 |
PF02798(GST_N)PF14497(GST_C_3) |
8 |
TYR A 7PHE A 8VAL A 10ARG A 13TRP A 38ILE A 104TYR A 108GLY A 205 |
EAA A 0
|
2GSS_B_EAAB0 |
2gss |
EAA DB00903(Etacrynicacid) |
Homo sapiens |
GLUTATHIONES-TRANSFERASE P1-1 |
no annotation |
8 |
TYR B 7PHE B 8VAL B 10ARG B 13TRP B 38ILE B 104TYR B 108GLY B 205 |
EAA B 0
|
2W13_A_ACTA1208 |
2w13 |
ACT DB03166(Aceticacid) |
Bothrops asper |
ZINCMETALLOPROTEINASEBAP1 |
PF01421(Reprolysin) |
4 |
THR A 31ARG A 32GLU A 35ASN A 133 |
ACT A1208
|
3GSS_A_EAAA212 |
3gss |
EAA DB00903(Etacrynicacid) |
Homo sapiens |
GLUTATHIONES-TRANSFERASE P1-1 |
PF02798(GST_N)PF14497(GST_C_3) |
7 |
TYR A 7PHE A 8VAL A 10ILE A 104TYR A 108THR A 109GLY A 205 |
EAA A 212
|
3GSS_B_EAAB211 |
3gss |
EAA DB00903(Etacrynicacid) |
Homo sapiens |
GLUTATHIONES-TRANSFERASE P1-1 |
no annotation |
7 |
TYR B 7PHE B 8VAL B 10ILE B 104TYR B 108THR B 109GLY B 205 |
EAA B 211
|
3IW1_A_ASDA1223 |
3iw1 |
ASD DB01536(4-Androstenedione) |
Mycobacteriumtuberculosis |
CYTOCHROME P450CYP125 |
PF00067(p450) |
12 |
ILE A 97VAL A 111GLN A 112PHE A 114VAL A 115MET A 200PRO A 213LYS A 214SER A 217ILE A 221VAL A 263VAL A 267 |
ASD A1223
|
3MG0_2_BO221405 |
3mg0 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME COMPONENTPRE3;PROTEASOME COMPONENTPUP1 |
PF00227(Proteasome)no annotation |
12 |
THR 2 1THR 2 20THR 2 21THR 2 22ALA 2 27LYS 2 33SER 2 46GLY 2 47ALA 2 49HIS V 114SER V 118SER 2 168 |
BO2 21405
|
3MG0_H_BO2H1400 |
3mg0 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME COMPONENTPUP1;PROTEASOME COMPONENTPUP3 |
PF00227(Proteasome)PF12465(Pr_beta_C) |
11 |
THR H 1SER H 20THR H 21GLN H 22LYS H 33ALA H 46GLY H 47THR H 48ALA H 49ASP I 114CYS I 118 |
BO2 H1400
|
3MG0_N_BO2N1404 |
3mg0 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME COMPONENTPRE3;PROTEASOME COMPONENTPUP1 |
PF00227(Proteasome)PF12465(Pr_beta_C)no annotation |
13 |
THR N 1THR N 20THR N 21THR N 22ALA N 27LYS N 33ARG N 45SER N 46GLY N 47ALA N 49HIS H 114SER H 118SER N 168 |
BO2 N1404
|
3MG0_V_BO2V1401 |
3mg0 |
BO2 DB00188(Bortezomib) |
Saccharomycescerevisiae |
PROTEASOME COMPONENTPUP1;PROTEASOME COMPONENTPUP3 |
no annotation |
11 |
THR V 1SER V 20GLN V 22ALA V 27LYS V 33ALA V 46GLY V 47THR V 48ALA V 49ASP W 114CYS W 118 |
BO2 V1401
|
4K38_A_SAMA504 |
4k38 |
SAM DB00118(S-Adenosylmethionine) |
;Clostridiumperfringens |
ANAEROBICSULFATASE-MATURATINGENZYME;KP18CYS PEPTIDE |
NonePF04055(Radical_SAM)PF13186(SPASM) |
12 |
CYS D 7TYR A 21TYR A 24GLN A 64GLU A 67GLN A 98SER A 122ARG A 134LEU A 163VAL A 165ILE A 192LEU A 195 |
SAM A 504
|
4K38_B_SAMB504 |
4k38 |
SAM DB00118(S-Adenosylmethionine) |
;Clostridiumperfringens |
ANAEROBICSULFATASE-MATURATINGENZYME;KP18CYS PEPTIDE |
None |
14 |
CYS C 7TYR B 21CYS B 22PHE B 23TYR B 24GLN B 64GLU B 67GLN B 98SER B 122ARG B 134LEU B 163VAL B 165ILE B 192LEU B 195 |
SAM B 504
|
4K39_A_SAMA504 |
4k39 |
SAM DB00118(S-Adenosylmethionine) |
;Clostridiumperfringens |
ANAEROBICSULFATASE-MATURATINGENZYME;CP18CYS PEPTIDE |
NonePF04055(SPASM)PF13186(Radical_SAM) |
13 |
CYS C 7TYR A 21PHE A 23TYR A 24GLU A 67GLN A 98ASN A 100SER A 122ARG A 134LEU A 163VAL A 165ILE A 192LEU A 195 |
SAM A 504
|
4LAJ_B_ACAB512 |
4laj |
ACA DB00513(AminocaproicAcid) |
Humanimmunodeficiencyvirus 1 |
HIV-1 YU2 GP120ENVELOPEGLYCOPROTEIN |
PF00516(GP120)no annotation |
6 |
ASP B 57PRO B 214HIS B 216ARG B 252ARG A 440GLY A 441 |
ACA B 512
|
4ODR_A_FK5A201 |
4odr |
FK5 DB00864(Tacrolimus) |
Homo sapiens;Thermusthermophilus |
PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD,PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A CHIMERA |
PF00254(FKBP_C)no annotation |
12 |
TYR A 13LEU A 15ASP A 23LEU A 27LEU A 36ILE A 37LEU A 40TYR A 63ILE A 71ILE A 72PHE A 80PRO B 102 |
FK5 A 201
|
4ODR_B_FK5B201 |
4odr |
FK5 DB00864(Tacrolimus) |
Homo sapiens;Thermusthermophilus |
PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD,PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A CHIMERA |
PF00254(FKBP_C)no annotation |
11 |
TYR B 13LEU B 15ASP B 23LEU B 27LEU B 36ILE B 37LEU B 40TYR B 63ILE B 71PHE B 80PRO A 102 |
FK5 B 201
|
4OQR_A_2UOA502 |
4oqr |
2UO DB06693(Mevastatin) |
Amycolatopsisorientalis |
CYP105AS1 |
PF00067(p450) |
9 |
PRO A 80TRP A 93VAL A 182ILE A 236VAL A 239ALA A 240THR A 244VAL A 282ALA A 388 |
2UO A 502
|
4R1Z_A_AERA601 |
4r1z |
AER DB05812(Abiraterone) |
Danio rerio |
CYP17A1 PROTEIN |
PF00067(p450) |
9 |
ALA A 126TYR A 214SER A 215ILE A 218ASP A 309GLY A 312ALA A 313THR A 317VAL A 493 |
AER A 601
|
4R1Z_B_AERB601 |
4r1z |
AER DB05812(Abiraterone) |
Danio rerio |
CYP17A1 PROTEIN |
no annotation |
7 |
ALA B 126SER B 215GLY B 312ALA B 313GLU B 316THR B 317SER B 378 |
AER B 601
|
5HKG_A_RAPA201 |
5hkg |
RAP DB00877(Sirolimus) |
Homo sapiens |
PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B |
PF00254(FKBP_C) |
13 |
TYR A 26ASP A 37PHE A 46GLN A 53GLU A 54VAL A 55ILE A 56PHE A 59TYR A 82HIS A 87VAL A 90ILE A 91PHE A 99 |
RAP A 201
|
5YN6_A_SAMA401 |
5yn6 |
SAM DB00118(S-Adenosylmethionine) |
Middle Eastrespiratorysyndrome-relatedcoronavirus |
NSP16 PROTEIN |
PF06460(NSP16) |
14 |
ASN A 43TYR A 47GLY A 71PRO A 80GLY A 81ASN A 98ASP A 99LEU A 100ASN A 101ASP A 114CYS A 115ASP A 130MET A 131PHE A 149 |
SAM A 401
|
5YNI_A_SAMA401 |
5yni |
SAM DB00118(S-Adenosylmethionine) |
Middle Eastrespiratorysyndrome-relatedcoronavirus |
NSP16 PROTEIN |
PF06460(NSP16) |
13 |
ASN A 43TYR A 47GLY A 71PRO A 80GLY A 81ASN A 98ASP A 99LEU A 100ASN A 101ASP A 114CYS A 115ASP A 130MET A 131 |
SAM A 401
|
5YNM_A_SAMA401 |
5ynm |
SAM DB00118(S-Adenosylmethionine) |
Middle Eastrespiratorysyndrome-relatedcoronavirus |
NSP16 PROTEIN |
PF06460(NSP16) |
13 |
ASN A 43TYR A 47GLY A 71PRO A 80GLY A 81ASN A 98ASP A 99LEU A 100ASN A 101ASP A 114CYS A 115ASP A 130MET A 131 |
SAM A 401
|
6F5U_A_CQNA610 |
6f5u |
CQN DB01244(Bepridil) |
Zaire ebolavirus |
ENVELOPEGLYCOPROTEIN;ENVELOPEGLYCOPROTEIN,ENVELOPE GLYCOPROTEIN,GP1 |
no annotation |
10 |
ARG A 64VAL A 66ALA A 101LEU A 184LEU A 186LEU B 515TYR B 517THR B 519MET B 548LEU B 558 |
CQN A 610
|
6F6I_A_8PRA509 |
6f6i |
8PR DB00715(Paroxetine) |
Zaire ebolavirus |
ENVELOPEGLYCOPROTEIN;ENVELOPEGLYCOPROTEIN,GP,GP1 |
no annotation |
12 |
ARG A 64VAL A 66LEU A 68GLU A 100ALA A 101GLY A 102LEU A 186LEU B 515TYR B 517THR B 519MET B 548LEU B 558 |
8PR A 509
|
6F6N_A_SREA508 |
6f6n |
SRE DB01104(Sertraline) |
Zaire ebolavirus |
ENVELOPEGLYCOPROTEIN;ENVELOPEGLYCOPROTEIN,ENVELOPE GLYCOPROTEIN,GP1 |
no annotation |
10 |
ILE A 38ARG A 64VAL A 66ALA A 101LEU A 184LEU A 186TYR B 517MET B 548LEU B 554LEU B 558 |
SRE A 508
|
6F6S_A_CXQA507 |
6f6s |
CXQ DB00245(Benzatropine) |
Zaire ebolavirus |
ENVELOPEGLYCOPROTEIN;ENVELOPEGLYCOPROTEIN,ENVELOPE GLYCOPROTEIN,GP1 |
no annotation |
5 |
ARG A 64ALA A 101TYR B 517GLN B 521ILE B 544 |
CXQ A 507
|
6F6S_B_CXQB705 |
6f6s |
CXQ DB00245(Benzatropine) |
Zaire ebolavirus |
ENVELOPEGLYCOPROTEIN;ENVELOPEGLYCOPROTEIN,ENVELOPE GLYCOPROTEIN,GP1 |
no annotation |
6 |
VAL A 66LEU A 184LEU A 186TYR B 517MET B 548LEU B 554 |
CXQ B 705
|